Last reviewed · How we verify
Citrobacter Urinary Tract Infection
Approved treatments
- Claforan · Sterimax
- Ciprofloxacine · Poitiers University Hospital
- Azactam · Bristol-Myers Squibb
Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent. - TICARCILLIN
- Ticarcillin
- Augmentin 250 · Dr Reddys Labs Inc
- Noroxin
- Floxin
- Cipro · Bayer AG
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Citrobacter Urinary Tract Infection patent landscape — cliff calendar, originator estates, attackable patents
- Citrobacter Urinary Tract Infection treatment landscape brief
- Citrobacter Urinary Tract Infection treatment updates RSS
Frequently asked questions about Citrobacter Urinary Tract Infection
What drugs treat Citrobacter Urinary Tract Infection?
Tracked treatments include Claforan, Ciprofloxacine, Azactam, TICARCILLIN, Ticarcillin, Augmentin 250, Noroxin, Floxin.
What is the treatment for Citrobacter Urinary Tract Infection?
Standard treatment for Citrobacter Urinary Tract Infection includes Claforan, Ciprofloxacine, Azactam, TICARCILLIN, Ticarcillin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Citrobacter Urinary Tract Infection patent cliff · Citrobacter Urinary Tract Infection CI report
- Treatment: Claforan · Sterimax
- Treatment: Ciprofloxacine · Poitiers University Hospital
- Treatment: Azactam · Bristol-Myers Squibb
- Treatment: TICARCILLIN
- Treatment: Ticarcillin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing